Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Approximate Bayesian evaluation of multiple treatment effects.

P F Thall1, R M Simon, Y Shen

  • 1Department of Biostatistics, M. D. Anderson Cancer Center, Houston, Texas 77030, USA. rex@odin.mdacc.tmc.edu

Biometrics
|April 28, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Phase I-II clinical trial design: a state-of-the-art paradigm for dose finding.

Annals of oncology : official journal of the European Society for Medical Oncology·2017
Same author

Fludarabine with pharmacokinetically guided IV busulfan is superior to fixed-dose delivery in pretransplant conditioning of AML/MDS patients.

Bone marrow transplantation·2016
Same author

PR1 peptide vaccine induces specific immunity with clinical responses in myeloid malignancies.

Leukemia·2016
Same author

Phase I/II trial of lenalidomide and high-dose melphalan with autologous stem cell transplantation for relapsed myeloma.

Leukemia·2015
Same author

A phase II randomized trial of induction chemotherapy versus no induction chemotherapy followed by preoperative chemoradiation in patients with esophageal cancer.

Annals of oncology : official journal of the European Society for Medical Oncology·2013
Same author

Adenoviral infections in adult allogeneic hematopoietic SCT recipients: a single center experience.

Bone marrow transplantation·2013
Same journal

Acknowledgment of Referees 2025.

Biometrics·2026
Same journal

Fast penalized generalized estimating equations for large longitudinal functional datasets.

Biometrics·2026
Same journal

Causally-interpretable random-effects meta-analysis.

Biometrics·2026
Same journal

Statistical inference for mean function of partially observed functional time series.

Biometrics·2026
Same journal

Subgroup identification via Interaction Tree and Mixed Model for Repeated Measures with application to Alzheimer's disease.

Biometrics·2026
Same journal

Finite mixtures of linear quantile regressions with concomitant variables: a solution to endogeneity in longitudinal data modeling.

Biometrics·2026
See all related articles

This study introduces a novel Bayesian approach for comparing experimental treatments against controls using randomized clinical trials with multiple patient outcomes. The method enhances treatment effect analysis by calculating posterior probabilities for different superiority and equivalence scenarios.

Area of Science:

  • Biostatistics
  • Clinical Trials Methodology
  • Health Services Research

Background:

  • Randomized clinical trials (RCTs) are crucial for evaluating new treatments.
  • Multivariate patient outcomes in RCTs present complex analysis challenges.
  • Existing methods may not fully capture nuanced treatment effects across multiple endpoints.

Purpose of the Study:

  • To develop an approximate Bayesian method for comparing experimental treatments to controls in RCTs with multivariate outcomes.
  • To provide a framework for assessing treatment superiority, equivalence, and discordance.
  • To offer a flexible analytical tool applicable to various clinical trial data types.

Main Methods:

  • Utilizes an approximate Bayesian approach to analyze treatment effects.

Related Experiment Videos

  • Characterizes overall treatment effect using a vector of parameters for individual outcomes.
  • Partitions the parameter space to define distinct regions of treatment superiority, equivalence, and discordance.
  • Computes posterior probabilities by treating parameter estimators as random variables within the Bayesian framework.

    • Main Results:

    • The proposed method allows for the computation of posterior probabilities for different treatment effect scenarios.
    • The approximation is valid for any setting with a consistent, asymptotically normal estimator of the parameter vector.
    • Demonstrated application to breast cancer time-to-event data and acute leukemia count data.

    Conclusions:

    • The approximate Bayesian method offers a robust framework for analyzing multivariate outcomes in clinical trials.
    • It facilitates a comprehensive understanding of treatment effects, including nuanced comparisons.
    • The method's versatility is shown through its application to diverse clinical datasets.